Article
PD ‐ L1 Promotes Immunological Tolerance and Enhances Visual Protection of hESC ‐ RPE Grafts in Retinal Degeneration
14 Feb 2025
Abstract excerpt
Immune rejection is a major barrier to the successful human embryonic stem cell-derived retinal pigment epithelial (hESC-RPE) transplantation for age-related macular degeneration (AMD). Traditional strategies to mitigate immune rejection involve ablating major histocompatibility complex (MHC) molecules on hESC-RPE. An alternative approach is immune checkpoint overexpression, avoiding natural killer (NK)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
